Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab with Chemoradiation in Cervical Cancer
NCT03527264Phase 2Terminated
- Sponsor
- Brown University
- Start
- Nov 2018
- Primary completion
- Nov 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in Cervical Cancer (CC), sponsored by Brown University. Started Nov 2018; status: terminated.
02
Drugs
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT03527264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03527264.